Heidi Fiegl

7PUBLICATIONS
35CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
The Tyrolean Founder MLH1 Variant c.836T>G Causes Lynch Syndrome Due to a Leaky Splice Effect.

|Jul 28, 2026
Early Normalization of Squamous Cell Carcinoma Antigen During Combined Chemoradiation Predicts Pathological Response and Survival in Squamous Cervical Cancer: A Retrospective Cohort Study.

|Dec 11, 2025
The Role of Plasmacytoid Dendritic Cells in the Immune Contexture of TP53-Mutated High-Grade Serous Ovarian Cancer.

Katharina Steger, Heidelinde Fiegl, Katja Rungger

|Oct 07, 2022
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.

Ankur Chakravarthy, Ian Reddin, Stephen Henderson

|Dec 14, 2021
The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents.

Gerlinde Karbon, Manuel D Haschka, Hubert Hackl

|Mar 01, 2019
NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer.

Christine Degasper, Andrea Brunner, Natalie Sampson

Pageof 2

Frequent Collaborators

2 joint publications

Alain Gustave Zeimet

2 joint publications

Hubert Hackl

2 joint publications

Christoph Ebner

2 joint publications

Katharina Steger